CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.69
+2.44%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$0.67
From 52W high−78.97%
Volume37688.00
Market cap$5.24M
P/E (TTM)—
P/S (TTM)1746.0x
Div yield—
Key dataNov 4, 2026
Open
$0.67
From 52W high
−78.97%
Volume
37688.00
Market cap
$5.24M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.6x
P/E (TTM)
—
RSI (14)
36.3
MomentumView details →
1D Return
+2.44%
YTD Return
−66.20%
SummaryUpdated Jun 1, 2026
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) is a biotechnology company founded in 2015 and based in Phoenix, Arizona. The company focuses on developing adult stem cell treatments across multiple medical specialties including immunology, urology, orthopedics, and neurology. Since going public in November 2015, CELZ has been in the clinical development stage, working to advance its portfolio of stem cell-based therapies for various medical conditions ranging from erectile dysfunction to stroke recovery.
Similar companies
Latest newsMore news →
Creative Medical Technology Holdings highlighted clinical findings from a six-month study of its investigational Ultrasome platform in 30 patients with bilateral knee osteoarthritis; 28 participants (93%) met the study-defined response criteria.15d agoCreative Medical Technology Holdings, Inc. acquired 4,000,000 shares of BioDefense, Inc. common stock from Creative Acquisition Corp. for $200,000 in cash and 1,000,000 shares of its own common stock, giving it an 80% ownership stake.40d ago